Skip to main content
ConductScienceScienceDex
NIH funding notice PAR-20-147

Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed)

Closed on May 7, 2023.

Posted
March 25, 2020
Close date
May 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $718,121 in first-year total cost, median $718,121.

Most frequent study sections

  1. Cellular and Molecular Technologies Study Section[CMT]1

Most frequent institutions

  1. UNIVERSITY OF WASHINGTON1
Competing awards under PAR-20-147 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Assessment of fetal brain health via circulating exRNA carriers for opioid use disorder in pregnancy1R01DA057748-01A1CHIU, DANIEL TVOJTECH, LUCIA NUNIVERSITY OF WASHINGTON, WA$718,121CMT

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
PAR-20-147: Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) | ScienceDex | ConductScience